throbber
a2) United States Patent
`US 9,314,412 B2
`(10) Patent No.
`Phinneyetal.
`(45) Date of Patent:
`Apr. 19, 2016
`
`
`US009314412B2
`
`(54) DEODORANT FORMULATION
`
`(71) Applicants:Robin Phinney, Okotoka (CA);
`Jonathon Phinney, Martensville (CA)
`
`(72)
`
`(*) Notice:
`
`Inventors: Robin Phinney, Okotoka (CA);
`Jonathon Phinney, Martensville (CA)
`Subject to any disclaimer, the term ofthis
`patent is extended or adjusted under 35
`US.C. 154(b) by 277 days.
`
`21)
`(21)
`(22)
`
`(65)
`
`Appl. No.: 13/803,387
`Appl.
`No
`,
`Filed:
`Mar. 14, 2013
`
`Prior Publication Data
`US 2014/0271517 Al
`Sep. 18, 2014
`
`(51)
`
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`
`Int. Cl.
`A6IK 8/27
`AGIK 8/23
`A61Q 15/00
`AGIK 8/19
`AGOIK 8/34
`A6IK 8/36
`AGIK 8/20
`(52) U.S.CL
`CPC ... A6IK 8/27 (2013.01); A61K 8/19 (2013.01):
`AG6IK 8/20 (2013.01); AGIK 8/23 (2013.01);
`AGIK 8/345 (2013.01); AGIK 8/361 (2013.01):
`A61Q 15/00 (2013.01)
`
`(58) Field of Classification Search
`CPC wees A61K 8/27; A61K 8/23; A61K 8/19;
`A61Q 15/00
`See application file for complete search history.
`
`(56)
`
`.
`References Cited
`U.S. PATENT DOCUMENTS
`3,943,242 A *
`3/1976 Fogel etal. vccceccsenn 424/65
`.......0.0.... 424/66
`2007/0202062 Al*
`8/2007 Workman etal.
`
`9/2011 Klugetal. wo. 424/66
`2011/0229427 A1*
`* cited by examiner
`
`Primary Examiner — Ali Soroush
`Assistant Examiner — Genevieve S Alley
`(74) Attorney, Agent, or Firm — Craig J. Lervick; Larkin
`Hoffman Daly & Lindgren, Ltd.
`
`ABSTRACT
`(57)
`Deodorant formulations are provided. The formulationsall
`commonly include magnesium oxide, zinc oxide and as a
`disinfecting agent, potassium chloride and/or potassium sul-
`phate. The combination provides long lasting odor protection
`since the disinfectant destroys odor causing microorganisms.
`The formulations all contain natural
`ingredients and the
`absence of petroleum basedor related synthetic compounds
`contributes to the efficacy of the formulations.
`
`7 Claims, No Drawings
`
`Petitioner Dr. Squatch
`Ex. 1004
`
`Petitioner Dr. Squatch
` Ex. 1004
`
`

`

`US 9,314,412 B2
`
`1
`DEODORANT FORMULATION
`
`TECHNICAL FIELD
`
`
`
`The present invention relates to a deodorant formulation
`and moreparticularly, the present invention relates to such a
`formulation and preparation thereof with natural ingredients
`in the absence of heavy metal complexes and/or petroleum
`basedor related compounds.
`
`BACKGROUNDOF THE INVENTION
`
`In a previous adaptation, Robin Phinney, in U.S. Pat. No.
`5,512,274, issued Apr. 30, 1996, taught a metal hydroxide
`deodorant formulation. In this document, milk ofmagnesia or
`magnesium hydroxide was found to be an effective deodor-
`ant. It was also found that a mixture ofthe hydroxidesof zinc
`and magnesium could provide long lasting protection against
`odour due to perspiration. The previous teachings provided
`that these materials are active ingredients, and are dispersible
`in aerosols, moisturizing creams, sticks, sprays and roll-on
`type applicators.
`The active hydroxide neutralizes 3-methyl-2-hexanoic
`acid and similar materials are largely responsible for body
`odourassociated with perspiration. These weak organic acids
`are produced bya bacterial action and require a moderately
`strong hydroxide type base to neutralize them and eliminate
`odour associated with, but not confined to perspiration.
`A vast array of compounds have been purported to combat
`perspiration and perspiration odour. In U.S. Pat. No. 3,996,
`346 issued Dec. 7, 1976, to Staffier et al., a rangeofacidic to
`neutral to basic salts are proposed as active ingredients to
`reduce body odour and/or stem perspiration. Manyofthe salts
`cited in the patent can be injuriousto the skin. Acid salts such
`as aluminum chloride, for example, hydrolyze to form hydro-
`chloric acid, which can be injuriousto both skin and clothing.
`Potassium alum has become widely available, and while
`effective as a deodorant, it hydrolyzes to form even more
`injurious sulphuric acid as well as aluminum ina soluble ionic
`form, which can lead to higher rates of absorption into the
`body than is the case with aluminum metal or alumina.
`These salts have hydrolysis points or protolysis reactions
`because they hydrolyze at different points on the pH scale
`
`(Chemistry of the Elements, Greenwood and Earnshaw,
`1984) and precipitate out of solution, primarily as hydrox-
`ides, at various pHs. For example, ferric hydroxide precipi-
`tates or hydrolyzes out of solution a pH of about 2.6 to 4.0
`while aluminum hydroxide precipitates or hydrolyzes out of
`solution in the range of 3.6 to 4.2.
`Othersalts, such as zinc, precipitate as hydroxides in the
`range of 6.5 to 8.0, but salts of these materials can behave in
`an erratic manner with many individuals in that they work
`effectively for very irregular periods oftime. In addition, zinc
`sulphate still releases sulphuric acid upon hydrolysis. The
`sporadicefficacy maybe dueto lack ofhydrolysis, conversion
`to relatively inactive carbonate or oxide, or some combination
`of these factors.
`
`Basic materials have been proposed, such as in U.S. Pat.
`Nos. 74,871; 1,558,406; 2,114,559; and 2,187,163, however,
`there are problems with most of these materials.
`The carbonates of U.S. Pat. No. 74,871, issued Feb. 25,
`1868, to Wilson, are very soluble and quickly leach from the
`skin during perspiration.
`The active agent of U.S. Pat. No. 1,558,406, a hexameta-
`phosphate, is soluble and liable to be washed away during
`perspiration. Being a phosphate,this agent could well serve as
`a majornutrient sourceofthe bacteria believed to be respon-
`
`2
`sible for body odour and this agent could thereby promote
`body odourrather than diminish it.
`USS. Pat. No. 1,558,405, issued May 3, 1983, to Marschner,
`contains mention of some of the same basic materials men-
`tioned in U.S. Pat. No. 74,781 and includes “‘sodium bicar-
`bonate, potassium bicarbonate, sodium or potassium carbon-
`ate, calctum hydroxide and the like ...”. The term “and the
`like” is vague, nebulous, undefined and unspecified given the
`previous explicit identification of agents. Materials men-
`tioned, such as potassium carbonate andlime, are very basic
`and could injure skin and clothing. This patent claims that
`basic agents need to be combined with “an absorptive
`insoluble filler material of emollient character, such as the
`stearate of zinc, aluminum or magnesium,or a mixture oftalc
`and small portions of zinc oxide”. The basic materials were
`said to lead to a drying action, which is offset by the healing
`action ofthe emollient. The patent does not prescribe deodor-
`ant formulations consistent with current understanding of
`mitigation of body odour dueto perspiration.
`While bases in high concentration may have “drying
`action”, they primarily neutralize acids as is evident to those
`skilled in the art. The only “anti-acid” body listed in the
`claims, which if compatible with the body, is sodium bicar-
`bonate. It is not capable ofneutralizing the agents responsible
`for body odour.
`The patent does notteachthat if the formulations had any
`significantefficacy, it did notarise from the action ofthe basic
`agent, sodium bicarbonate, cited in the claim but from some
`other material or combination of materials. Metal stearates,
`the so-called “absorptive insoluble filler material of an emol-
`lient character” of the formulation, might, under somecir-
`cumstances, be responsible for some, if any, activity associ-
`ated with the formulation cited in this patent. Another
`possibility is zinc oxide, but it along with many other “basic”
`metal oxides like alumina are very unreactive against perspi-
`ration odour due to insolubility and low hydrolysis rate to a
`hydroxide form that could show someactivity.
`‘he filler materials are first and foremost sparingly soluble
`neutral metallic salts of a weak organic acid which would
`only be weakly hydrolyzedto a potentially active agent with
`the aluminum salt having the best potential for any efficacy
`due to its low hydrolysis pH.
`Thezinc salts would show someerratic behaviour as noted
`
`before but would be strongly inhibited by being coupled toa
`weakly dissociated organic acid. The magnesium salt would
`be no moreeffective than Epsom salts since it has no capacity
`of generate basic deodorizing agent through dissolution in
`water.
`The zinc stearate cited as the emollient could have some
`
`antiperspirantactivity but is likely subjectto the erratic activ-
`ity noted earlier for zinc salts. The stearate portion could
`supply organic material to foster undesirable bacterial growth
`and therefore be undesirable.
`USS. Pat. No. 2,187,163, issued Jan. 16, 1940, to Langer,
`identifies the use of “base”carrier materials such as kaolin or
`calamine with the latter being preferred when combined with
`active deodorant materials such as aluminum andzinc chlo-
`
`ride. Calamine, zinc oxide and sulphates of aluminum and
`zinc are claimed as active agents. It is said that these formu-
`lations supplanted with other agents such as tannic acid and/
`or salicylic acid “havethe property of preventing or reducing
`perspiration and of acting as deodorants in this manner’’.
`Oxides and carbonates of “acceptable” antiperspirant
`agents, such as alumina and calamine, are generally ineffec-
`tive in reducing body odour because they are inactive with
`respect to the weak organic acid responsible for perspiration
`odourfor reasons of equilibrium, kinetics and solubility. Sul-
`
`10
`
`30
`
`40
`
`45
`
`50
`
`60
`
`

`

`US 9,314,412 B2
`
`3
`phates of zinc, unlike those of aluminum,have been observed
`to be erratic performers likely because they do not hydrolyze
`effectively. The author claimsthat the sulphates of aluminum
`and zinc have the property of reducing or preventing perspi-
`ration and act as deodorants in this manner.
`
`Thereis no evidence in thetext to support this assertion and
`it is evident to those skilled in the art that neither compound
`would act to any significant extent as a desiccant. These
`agents most likely act in a different manner and understand-
`ing of the mechanism ofthis action could result in a signifi-
`cantly different approach in formulating materials with
`greater efficacy.
`Body odour is knownto those skilled in the art to be due
`primarily to the products of bacterial action and not moisture
`as such.
`US. Pat. No. 3,996,346, issued Dec. 7, 1976, to Staffier et
`al., cites zine oxide and calcium hydroxide along with phenol
`as an effective deodorant. As is evident by thecitation of U.S.
`Pat. No. 1,558,405, the use of lime as deodorant agent has
`been noted some time ago. Given the low activity of zinc
`oxide as a deodorant agent, it is likely that any observed
`deodorant activity is due to the lime. Limeis quite basic with
`reported pHs of 12.5 and higher. While lime hasthe capability
`to function as an effective agent against odour, it is less
`desirable than other agents dueto its alkalinity. The zinc oxide
`combined with stearic acid as a cream base mostlikely is an
`attempt to minimize the undesirable effects due to high alka-
`linity and the general undesirable nature of phenyls in skin
`care products.
`Sincethe initial formulation wasdisclosed in U.S. Pat. No.
`5,512,794, there have been several hundred additional patents
`issued with a like number of applications filed. As an
`example, United States Patent Application Publication
`US2008/0131387, filed Dec. 6, 2007 and published Jun. 5,
`2008, provides for a liquid stick antiperspirant. The disclo-
`sure indicates that the formulation contains materials for pre-
`serving thestability of the formulation. To this end, a number
`of petroleum based compoundsare used.
`In USS. Pat. No. 7,703,767, issued Dec. 4, 2007, to Withiam
`et al., a personal care formulation is disclosed. The formula-
`tion coats metal silicates for improved odourneutralization.
`Although useful, the formulation incorporates several syn-
`thetic compounds whichinherently limits the efficacy.
`In summary, there is a wide range of active ingredients
`cited in the open andpatentliterature for prevention of body
`odour and perspiration but most have some undesirable char-
`acteristics. Many formulations use aluminum chloride or
`other aluminum compounds based on sulphates for example
`that form irritating acids. As well, human exposure to alumi-
`num is raising health concerns. Other formulations recom-
`mend materials, such as potassium carbonate, that can be
`harmfulto the skin, or salts of zinc that have minimalefficacy
`due to poor hydrolysis to active hydroxide.
`There is, therefore, a need to provide alternative deodorant
`formulations that balance the need for performance, efficacy,
`simplicity, and compatibility of the formulation with good
`health care in conjunction with a technically sound under-
`standing of the reason for body odour and therefore the cor-
`rect abatement measuresto take.
`
`SUMMARYOF THE INVENTION
`
`This invention aids in fulfilling these needs intheart.
`Oneobject ofone embodimentofthe present inventionis to
`provide a deodorant formulation, comprising a polyol, glyc-
`erine; a disinfectant agent comprising at least one of potas-
`sium chloride and potassium sulphate for destroying micro-
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`4
`organisms associated with odour; zinc oxide; magnesium
`oxide; sodium stearate; water; and a cosmetically acceptable
`filler.
`
`The content of the zinc oxide and magnesium oxide can
`vary in the case of zinc oxide between 0.5% to 10% by weight
`of the formulation. In a specific example, the range will be
`between 0.5% and 1.5% by weight of the formulation; in
`respect of the magnesium oxide, the amount can vary from
`between 1% and 10% by weight of the formulation with a
`specific example being between 1.5 and 2.5% by weight.
`A further object of one embodimentis to provide a deodor-
`ant formulation comprising: propylene glycol in an amount of
`between 52% and 57% by weight of said formulation; glyc-
`erine in an amountof between 6% and 10% by weightofsaid
`formulation; a disinfectant agent comprising at least one
`potassium chloride and potassium sulphate in an amount of
`between 0.5% and 1% by weight of said formulation for
`destroying microorganismsassociated with odour; zinc oxide
`in an amount between 0.5% and 1.5% by weight of said
`formulation; magnesium oxide in an amount between 1.0%
`and 2.5% by weight ofsaid formulation; sodium stearate in an
`amount between 4% and 8% by weight of said formulation;
`water in an amount between 18% and 22% by weight; and a
`balance of a cosmetically acceptablefiller.
`A further object of another embodiment is to provide a
`deodorant
`formulation, comprising a solid stick based
`deodorant formulation, comprising a propylene glycol in an
`amount of between 52% and 57% by weight of said formu-
`lation; glycerine in an amount of between 6% and 10% by
`weight of said formulation;a disinfectant agent comprising at
`least one potassium chloride and potassium sulphate in an
`amount of between 0.5% and 1% by weightof said formula-
`tion for destroying microorganisms associated with odour;
`zinc oxide in an amount between 0.5% and 1.5% by weight of
`said formulation; magnesium oxide in an amount between
`1.0% and 2.5% by weight of said formulation; sodium stear-
`ate in an amount between 4% and 8% by weight of said
`formulation; water in an amount between 18% and 22% by
`weight; a cosmetically acceptable thickener in an amount
`sufficient to provide a consistency for said formulation; and
`the balance comprising water.
`In both ofthese embodiments, the disinfecting and deodor-
`izing formulations can be used as precursory mixture for
`other formulations and uses.
`
`As a further object of one embodiment of the invention,
`there is provided is a method of formulating a deodorant
`formulation, comprising providing magnesium oxide, zinc
`oxide and potassium sulfate or potasstum chloride; mixing
`said magnesium oxide and said zinc oxide components of
`step a) with water to convert said componentsto their respec-
`tive hydroxides; mixing a polyol into the mixture; heating
`said mixture to 80° C.; emulsifying said mixture with the
`addition of sodium stearate; maintaining the emulsified mix-
`ture at a temperature between 60° C. and 80° C. to remove any
`trapped gas; and cooling said mixture to slightly above the
`solidification point.
`Yet another object of one embodiment is to provide a
`method of formulating a deodorant composition, comprising:
`providing MgO, ZnO andpotassium sulfate or potassium
`chloride; mixing said magnesium oxide andsaid zinc oxide
`componentsof step a) with water to convert said components
`to their respective hydroxides; mixing a polyol into the mix-
`ture; heating said mixture to 80° C.; emulsifying said mixture
`with the addition of sodium stearate; maintaining the emul-
`sified mixture at a temperature between 60° C. and 80° C. to
`remove any trapped gas; and cooling said mixtureto slightly
`abovethe solidification point.
`
`

`

`US 9,314,412 B2
`
`5
`A still further object of one embodimentis to provide a
`deodorant formulation, comprising by weight of the formu-
`lation: 55% propylene glycol; 20% water; 12% glycerine; 8%
`Sodium Stearate; 2.5% MgO; 1.5% ZnO; and 1% KCl.
`
`DETAILED DESCRIPTION OF THE PREFERRED
`EMBODIMENTS
`
`It has been discussed in U.S. Pat. No. 5,512,274, that there
`are problems associated with the active agents used in many
`deodorant formulations as notedin thepriorart. In searching
`for a suitable formulation, the objective was to find an agent
`or agents that acted as deodorants rather than antiperspirants.
`However, it will be evident to those skilled in the art that an
`agent effective as a deodorant could well be part ofthe basis
`for an antiperspirant formulation using materials obvious to
`those skilled in theart for the purpose of combating wetness.
`As reported, certain organic acids, such as 3-methyl-2-
`hexanoic and others (George Preti of the Monell Chemical
`Senses Center in Philadelphia), are primarily responsible for
`disagreeable odours generally associated with perspiration
`and produced by microorganisms.
`A previously presented solution wasto neutralize the acid
`produced and thereby eliminate the odour of the acid by
`forming a salt of the hexanoic acid with a suitable base.
`Strong basescited in theprior art, such as potassium carbon-
`ate, are not good becausethey are so basic that they cause skin
`damage and they are also so soluble that they rapidly wash
`away under heavy perspiration providing a very low duration
`of protection.
`Conventional basic agents need to yield a pH of 9 to 10 as
`a minimum to be effective but not extend much abovethis
`level to avoid skin irritation. The base must behave in such a
`
`mannerthat it does not wash awaylike soluble carbonates or
`more simply, the base should be sparingly soluble and with
`the requisite pH requirements, function on a stand alone
`basis, and not be harmful to the skin.
`At the same time, a metal hydroxide base is preferred due
`to its high activity compared to metal carbonates, such as
`limestone or other such benign carbonates, when trying to
`neutralize a weak organic acid. As well, a metal hydroxideis
`preferred over metal oxides since many show very low solu-
`bilities and negligible reactivities like alumina. Lime has
`been previously identified as a deodorant ingredient, butits
`high pH rules outdirect application.
`A suitable and simple agent previously presented in U.S.
`Pat. No. 5,512,274, before is magnesium hydroxide, (milk of
`magnesia). It has low solubility and therefore does not “wash
`away” under heavy perspiration. The pH is in the range of
`10.0 and magnesium hydroxide provides 16-20 hour protec-
`tion and more for a broad cross section of people.
`The magnesium hydroxide incorporated in a formulation
`of the invention for controlling perspiration odour such that
`the formulation has a pH of about 9 to about 10.5. Preferably,
`the pH of the formulation is about 10. The formulations
`discussed herein include zinc hydroxide This combination
`provides for a pH of about7.5 to about 10.5, preferably about
`9 to about 10. The zinc hydroxide typically lowers the pH of
`the magnesium hydroxide-perspiration odour-controlling
`formulation of the invention.
`Tt has now surprisingly been found that incorporation of a
`disinfectant with the platform of magnesium oxide and zinc
`oxide base hasparticularefficacy in destroying the microor-
`ganismscausing the odour.It is believed that the previously
`recognized synergy between the zinc and magnesium com-
`pounds has been further augmented with the disinfection
`capacity of a potassium and/or sulfate potassium chloride.
`
`30
`
`40
`
`45
`
`50
`
`60
`
`6
`As an appealing benefit, the formulations do not contain
`aluminum compounds which, as discussed supra are con-
`tributory to acid synthesis coupled with potential health con-
`cerns. Further, the formulations do not contain any synthetic
`petroleum based products inherent in the vast majority of the
`existing formulations presently available. The formulations
`presented herein are natural minerals with organic thickeners
`all of which are water soluble and environmentally friendly.
`Given the simplicity of the active ingredients in the formu-
`lation, the same lendsitselfto a variety of deodoranttypes. As
`an example, the formulation can be prepared as a stick, spray,
`gel, cream as well as precursor formulations of the active
`ingredients only to allowfor subsequentfinal formulation by
`an end user as another deodorant product.
`In keeping with the all natural ingredients, natural organic
`thickeners can be employed such as polysaccharides, a suit-
`able example of which is Amigel, a trademark of the Alban
`Muller company. Other suitable examples include guar guar,
`carrageenan, xanthan, gum tragacanth, gum Arabic, gum
`karaya, locust bean gum inter alia. These are exemplary and
`not meant to be limiting. A broad range of possibilities is
`readily within the purview of one skilled.
`Other agents may be incorporated into the formulation
`such as fragrance, spreadability enhancing agents, glide
`agents, moisturisers, cooling agents, etc. As an example, pro-
`panediol, a trademark ofDuPont Tate & Lyle Bio Products, is
`a corn derived glycol which is knownto provide a silky
`feeling with high stability and spreadability. These attributes
`are very beneficial for underarm deodorant formulations.
`Turning to the specific formulations, in a first embodiment,
`the deodorant formulation includes magnesium oxide in an
`amount of between 1% and 2.5% by weight and zinc oxide in
`an amount of between 0.5% and 1.5% by weight. In order to
`further augmenttheefficacy ofthe formulation,a disinfectant
`agent is included. As an example, potassium sulfate in an
`amountofbetween 0.5% and 1% by weight. Propylene glycol
`in an amount between 45% and 57% by weight is included.
`Other polyols may be substituted such as glycenol, etc.
`Sodium stearate is also present in am amount between 4% and
`8% by weight. Glycerin is also present in an amount from
`between 6% and 10% by weight. The balance of the formu-
`lation is obviously water. The sulphate compound has been
`foundparticularly effective in destroying the microorganisms
`responsible for the odour in perspiration. The provision for
`the suspension is very convenient, since the active ingredients
`are all present and this suspension can used as a precursorin
`the formulation of other deodorizing products.
`It is envisioned that the formulation could be easily com-
`bined with soaps, detergents, fabrics etc. to form a panoply of
`deodorizing products.
`In respect of the specific formulations, the same may take
`any numberof actual forms; a cosmetically acceptable thick-
`ener in an amountsufficient to provide a gel consistency for
`the formulation is provided and may be chosen from those
`noted above. As an option, the formulation may also contain
`1,3 propanediol for purposes of glide for comfort in applica-
`tion.
`For the formulations of the invention ethyl alcohol may be
`includedto act as a dispersant for the magnesium oxide and
`zine oxide. In addition, the ethyl alcohol aids drying of the
`formulation on the surface to which the formulation is
`applied, thus avoiding extended wetness.
`It will be understood that other materials that perform the
`functions associated with the ethyl alcohol can be used in
`combination with ethyl alcohol or substituted for the ethyl
`alcohol.
`
`

`

`US 9,314,412 B2
`
`7
`Although it may seem evident after an overview of the
`chemistry of acids, bases, salts, hydrolysis theory and the
`theory of odour due to perspiration, the combined use of
`magnesium oxide, zinc oxide together with a bactericidal
`agent for microorganism control has not been previously
`identified.
`
`Tt is known from the earlier Phinney U.S. patent that metal
`hydroxides are active agents against body odour, together
`with zinc hydroxide, which is active even though it is more
`neutral than milk ofmagnesia. As well, zinc has a well known
`salutary effect on the skin. Several deodorant formulations
`use zine oxide; however, as noted before, of the group of
`metal oxides that could be considered safe for human use,
`most hydrate to the active hydroxide form very slowly. For
`example, as in the Bayer aluminum process, strong caustic
`soda is required to transform aluminato the hydroxide form in
`high yield.
`Sulphates and chlorides of zinc hydrolyze to zinc hydrox-
`ide in an erratic manner because the protolysis reaction is
`muchless extensive than with aluminum chloride or potas-
`sium alum, for example.
`Greenwood and Earnshaw refer to metal salt hydration as
`hydrolysis or protolysis reactions having some similarity to
`acidity scales. The literature, such as Chemical Reviews 1957
`and Progress in Physical Organic Chemistry, document a
`variety of acidity and basicity scales based not only on the
`pioneering work of Louis P. Hammett but concepts such as
`carbon acidity and basicity.
`Ralph G.Pearson proposedin 1966 (Journal of the Ameri-
`can Chemical Society) a very broad concept of acids and
`bases called HSAB that went beyond the Bronstead and
`Lewis theory of acids and bases to include a wider range of
`phenomenathat coverthe concept ofcation acidity, which can
`be used, in conjunction with solubility phenomena,to ratio-
`nalise protolysis reactions as observed with salts such as
`aluminum chloride.
`With an absorber such as body oils, HCl from aluminum
`chloride hydrolysis is absorbed. The aluminum cation is so
`“acidic”that it reacts with water as a “base” and formsalu-
`
`minum hydroxide which can then neutralize hexanoic acid.
`Atthe other end ofthescale, a salt like magnesium sulphate
`has a magnesium cation that cannot “hydrolyze”or has insuf-
`ficient cation acidity to form magnesium hydroxide, and con-
`sequently cannot act as an effective deodorant. The formal
`hydroxide form of magnesium must be used for deodorant
`purposes.
`Salts of the zinc do not have enoughcation acidity to form
`zinc hydroxide to any effective degree except to the extent
`that most soaps impart somealkalinity causing the formation
`of zinc hydroxide. Hencethe sporadic action of zinesalts and
`the need to use zinc oxide as a deodorantrather than zincsalts.
`
`The above formulations of magnesium, zinc and sulfates
`can require moisturizing agents to ensure that thereis avail-
`able hydroxide in solution on the skin’s surface. Neutral salts
`are preferred with lowersolubilities being favored. Examples
`of suitable moisturizing agents are Epsom salts, Glaserite,
`and kainite.
`The formulation of the invention can also contain a non-
`
`toxic, non-corrosive, double salt having water of hydration
`and a pH ofabout 5 to about 8 when dissolved in water. The
`double salt is employed in an amount sufficient to increase
`retention of the magnesium hydroxide, and zinc hydroxide,
`on the surface to which the formulation is applied in the
`presence of humanperspiration. The double salt thus aids in
`minimizing the likelihood that the formulation of the inven-
`tion will “wash away”in the presence of heavy perspiration.
`
`8
`The formulation ofthe invention can be applied to a surface
`in contact with human perspiration. Thus, for example, the
`formulation can be applied to the skin of a human,such asthe
`underarm or foot areas. As another example, the formulation
`can be applied to a garmentin contact with perspiration, such
`as a sock or shoe.
`The admixture of zinc and magnesium oxides together
`with the sulfates has yielded deodorantprotection for signifi-
`cant extended periods of time. In effect, the formulations
`offer a “double” degree of protection. One from the zinc and
`magnesium compoundspreviously discovered by Applicant
`and the secondbeingthe disinfectantaction of the potassium
`chloride or potassium sulphate. Accordingly, even in the
`worst cases of perspiration, odour is checked, since the for-
`mulation incorporates the bactericidal agent.
`Although embodiments of the invention have been
`described above,it is not limited thereto and it will be appar-
`ent to those skilled in the art that numerous modifications
`form part ofthe present invention insofar as they do not depart
`from thespirit, nature and scope ofthe claimed and described
`invention.
`
`In respect of greater detail regarding the formulation, mag-
`nesium oxide and zinc oxide must have high reactivity and are
`added to water along with potassium sulfate and mixed until
`the magnesium oxide and zinc oxide are converted to their
`hydroxides. This generally occurs within an hour. The polyols
`are added and the mixture heated andstirred until the tem-
`perature reaches 80° C. At this point, sodium stearate is added
`slowly and the mixture is shear mixed to completely emulsify
`the mixture. The shear mixing is conducted for between 5 and
`10 minutes.
`The mixture is mixed normally and held at a temperature
`between 60° C. and 80° C. for approximately an hour to
`removeair bubbles. Color or fragrance may be addedatthis
`time. The mixture is then cooled to between 50° C. to 60° C.,
`slightly above the solidification point and stirred vigorously
`and quickly poured into deodorant containers (not shown).
`‘The containers must be cooled quickly to between 20° C. and
`40° C.
`
`The magnesium oxide and zinc oxide must be completely
`converted to their hydroxides or skinirritation will occur.
`The magnesium oxide and zinc oxide ratio has been found
`effective at 3:1 molar.
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`Weclaim:
`
`1. A deodorant formulation in a solid stick form, compris-
`ing:
`a polyol;
`glycerine;
`at least one of potassium chloride and potassium sulphate;
`zinc hydroxide;
`magnesium hydroxide;
`sodium stearate;
`water; and
`a cosmetically acceptablefiller;
`wherein said magnesium hydroxide and said zine hydrox-
`ide are present in a molarratio up to about 3:1.
`2. The formulation as set forth in claim 1, wherein said
`polyolis propylene glycol.
`3. A deodorant formulationin solid stick form, comprising:
`propylene glycol in an amount of from 52% to 57% by
`weight of said formulation;
`glycerine in an amount of from 6% to 10% by weight of
`said formulation;
`at least one of potassium chloride and potassium sulphate
`in an amount from 0.5% to 1% by weightof said formu-
`lation;
`
`50
`
`55
`
`60
`
`65
`
`

`

`US 9,314,412 B2
`
`9
`zinc hydroxide in an amount from 0.5% to 1.5% by weight
`of said formulation;
`magnesium hydroxide in an amount from 1.0% to 2.5% by
`weight of said formulation;
`sodium stearate in an amount from 4% to 8% by weight of 5
`said formulation;
`water in an amount from 15% to 20% by weight; and
`a balance of a cosmetically acceptablefiller,
`wherein said magnesium hydroxide and said zine hydroxide
`are present in a molar ratio UP to about 3:1.
`4. The formulation as set forth in claim 3, wherein said
`formulation further includes a member selected from the
`
`10
`
`15
`
`group consisting of a humectant, a glide agent, emollient,
`PABA, panthenol, lanolin, jojoba, ceramides, candela wax,
`beeswax,aloe vera, allantoin, anti-oxidants, butylene glycol,
`carbomers,
`caprylic/capric
`triglyceride,
`cetyl
`alcohol,
`cyclomethicone dimethicone, disodium emulsifying wax eth-
`ylparaben,glycerin, glyceryl stearate, hydrolyzedoatprotein,
`methylparaben omental polysorbate 80, propylparaben,
`stearic acid, triethanolamine, Vitamin A, Vitamin C, Vitamin 20
`E or tocopherol acetate, and shea butter.
`5. The formulation as set forth in claim 4, wherein said
`formulation further comprises a cosmetically acceptable
`thickener selected from the group consisting of guar guar,
`carrageenan, xanthan, gum tragacanth, gum Arabic, gum 25
`karaya, and locust bean gum.
`6. The formulation as set forth in claim 3, further including
`a cosmetically acceptable fragrance.
`7. A deodorant formulation in a solid stick form, compris-
`ing by weight of said formulation: 55% propylene glycol; 30
`20% water; 12% glycerine; 8% Sodium Stearate; 2.5%
`MgOH; 1.5% ZnOH; and 1% KCl.
`*
`*
`*
`*
`
`*
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket